Karyotyping is a foundational technique in clinical cytogenetics that allows scientists to visualize an individual’s complete set of chromosomes. By arranging chromosome pairs according to size, banding pattern, and centromere position, this method reveals numerical abnormalities, large structural rearrangements, and regions of homozygous loss. Modern high-resolution approaches combine classical staining with molecular probes, yet the core principle remains the assessment of chromosome integrity and number.
Biological and Clinical Rationale
Human cells typically contain 46 chromosomes, organized into 23 pairs. Aneuploidy, translocations, deletions, and duplications can disrupt development, fertility, and cancer progression. Karyotyping translates microscopic images into a standardized report, providing a snapshot of genome stability. For expectant parents, individuals with recurrent miscarriage, or patients with congenital anomalies, this analysis helps clarify etiology and guide management decisions.
Sample Collection and Transportation
Peripheral blood lymphocytes are the most common starting material, but bone marrow, amniotic fluid, chorionic villi, and solid tumors can also be analyzed. Collection follows strict biosafety and ethical protocols, using heparinized tubes for blood or specialized media for cell cultures. Rapid transport to a certified laboratory, maintenance at 20–24°C, and precise timing of culture initiation are critical to obtain high-quality metaphase spreads with well-defined banding.
Laboratory Procedure Overview
The workflow encompasses cell culture, mitotic arrest, hypotonic treatment, fixation, slide preparation, staining, and microscopic evaluation. Each step influences chromosome morphology and banding quality. Technologists must optimize incubation times, reagent concentrations, and harvesting intervals to maximize metaphase yield and minimize artifacts. Detailed documentation ensures traceability and supports troubleshooting when results are ambiguous.
Cell Culture and Mitotic Arrest
Incubate cells in a growth medium containing phytohemagglutinin to stimulate division.
Add colchicine or colcemid during the final hours to freeze cells in metaphase.
Monitor cultures microscopically to determine peak metaphase density before harvesting.
Hypotonic Treatment and Fixation
Expose cells to a hypotonic solution to swell nuclei and separate chromosomes.
Fix cells in a methanol-acetic acid mixture to preserve structure and remove excess cytoplasm.
Perform multiple drops onto clean slides to promote spreading and banding contrast.
Staining and Banding Analysis
Apply Giemsa stain for G-banding, revealing characteristic light and dark bands.
Evaluate slides at high magnification to identify each chromosome pair.
Capture images using digital systems, then assemble homologs into karyotypes according to the International System for Human Cytogenomic Nomenclature.
Interpreting the Karyotype Report
Results are reported using standardized nomenclature that describes chromosome number, sex chromosomes, and any gains or losses. Normal female and male karyotypes are designated 46,XX and 46,XY. Abnormal findings may include trisomies, monosomies, translocations such as t(9;22) in chronic myeloid leukemia, or complex rearrangements. Clinicians correlate these data with phenotype, family history, and molecular testing to refine diagnosis and counseling.
Quality Control and Emerging Techniques
Rigorous internal and external quality assessments underpin reliable karyotyping. Technologists verify reagent performance, participate in proficiency testing, and cross-check ambiguous findings with secondary assays. Contemporary enhancements include spectral karyotyping and comparative genomic hybridization, which can detect smaller imbalances. Nevertheless, conventional banding remains indispensable for precise breakpoint mapping and for validating next-generation sequencing data in cancer genetics.
